SEARCH:   Advanced

Blood, Vol. 111, Issue 5, 2538-2547, March 1, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Long-term imatinib therapy promotes bone formation in CML patients Blood Fitter et al. 111: 2538 Supplemental materials for: Fitter et al Files in this Data Supplement: Table S1. Assessment of disease indices for CML patients at diagnosis and after imatinib mesylate or α-interferon therapy (PDF, 119 KB) Table S2. Patient serum electrolyte levels as measured at diagnosis of CML and after imatinib mesylate or α-interferon therapy (PDF, 75.8 KB) This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020